Molecular Mechanisms and Diagnosis of Mastocytosis
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Mastocytosis is a disorder characterized by presence of excessive numbers of mast cells in skin, bone marrow and internal organs. It can affect both children and adults, males and females and individuals from all ethnic backgrounds, although precise demographic information about the affected populations is not available as it is a rare disorder. Mastocytosis in children is generally limited to the skin and follows a self limited course, while it is a disorder of the hematopoietic stem cell associated with somatic mutations of the c-kit gene in most patients with adult-onset of disease. There is no known curative therapy for most patients with systemic mastocytosis. Recent research studies identified several subtypes of disease with distinct clinical and pathologic features, however, a precise understanding of the incidence as well as molecular pathology of different disease subtypes is lacking. This study aims to examine molecular and cellular pathological aspects of disease in patients with mastocytosis and correlate findings with clinical presentation and prognosis. Patients will undergo a routine history and physical examination, and diagnostic tests will be ordered as dictated by each patient's clinical presentation. Blood and bone marrow will be obtained for diagnostic and research purposes. Genetic analysis of the c-kit gene regulating mast cell growth and differentiation will be performed. It is hoped that findings obtained from this study will help to design novel therapies for mastocytosis and other disorders in which mast cells play a critical role.
| Condition |
|---|
|
Mastocytosis |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Investigation of Cellular and Molecular Pathologic Mechanisms in Mast Cell Disorders. |
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Patients with confirmed or suspected mast cell disease
Inclusion Criteria:
- Confirmed or suspected diagnosis of mastocytosis.
- Ability to give informed consent (by the patient or legal guardian if minor)
Exclusion Criteria:
- Inability or not willing to provide informed consent.
Contacts and Locations| Contact: Cem Akin, M.D., Ph.D. | 734-647-6234 | cemakin@umich.edu |
| Contact: Echo Reed | 734-936-5634 | echoreed@umich.edu |
| United States, Michigan | |
| University of Michigan | Recruiting |
| Ann Arbor, Michigan, United States, 48109 | |
| Contact: Cem Akin, M.D., Ph.D. 734-647-6234 cemakin@umich.edu | |
| Principal Investigator: Cem Akin, M.D., Ph.D. | |
| Principal Investigator: | Cem Akin, M.D., Ph.D. | University of Michigan |
More Information
Publications:
| Responsible Party: | Cem Akin, University of Michigan |
| ClinicalTrials.gov Identifier: | NCT00336076 History of Changes |
| Other Study ID Numbers: | 2004-0246 |
| Study First Received: | June 8, 2006 |
| Last Updated: | February 12, 2009 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Michigan:
|
Mast cell disease Anaphylaxis c-kit Mutation Mastocytosis (suspected or proven) |
Additional relevant MeSH terms:
|
Mastocytosis Urticaria Pigmentosa Mastocytoma Neoplasms, Connective Tissue Neoplasms, Connective and Soft Tissue |
Neoplasms by Histologic Type Neoplasms Skin Diseases Mastocytosis, Cutaneous Pigmentation Disorders |
ClinicalTrials.gov processed this record on May 23, 2013